Suppression of AVIC inflammosteogenesis for prevention of CAVD progression
抑制 AVIC 炎症生成以预防 CAVD 进展
基本信息
- 批准号:9291498
- 负责人:
- 金额:$ 38.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgeAlkaline PhosphataseAlpha CellAnti-Inflammatory AgentsAnti-inflammatoryAttenuatedBlood flowCCL2 geneCalcifiedCalciumCardiovascular DiseasesCardiovascular Surgical ProceduresCellsCellular StructuresCholesterolChronicComplement Factor BCoronary arteryDepositionDiseaseDisease ProgressionElderlyEndothelial CellsFailureGoalsHealthcareHeart failureHigh Fat DietHumanHyperlipidemiaIL8 geneIRAK1 geneImmunologic ReceptorsInflammationInflammation MediatorsInflammatoryIntercellular adhesion molecule 1Interleukin-1 ReceptorsInterleukin-6InterventionKnowledgeLesionLongevityMAPK3 geneMediatingMediator of activation proteinMolecularMusNF-kappa BNoduleNonesterified Fatty AcidsObesityObstructionOperative Surgical ProceduresPathogenesisPharmacologyPlasmaPlayPreventionPublishingRecombinantsResearchRisk FactorsRoleTLR2 geneTLR4 geneTestingTherapeuticTissuesToll-like receptorsUp-Regulationaortic valveaortic valve disorderaortic valve replacementbone morphogenetic protein 2calcificationcytokineenhancing factorexposed human populationfeedinghuman diseaseinsightinterleukin-18 receptorinterstitial cellknock-downosteogenicoxidized low density lipoproteinpublic health relevanceresponsetherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Calcific aortic valve disease (CAVD) is a leading cardiovascular disorder in the elderly. Currently, pharmacological intervention for slowing down or halting the progression of this disease is unavailable. Our recent studies found that human aortic valve interstitial cells (AVICs) express both inflammatory and osteogenic mediators in response to pro-inflammatory stimulation and display up-regulates pro-osteogenic activity characterized by elevated levels of alkaline phosphatase (ALP) and the formation of calcification nodules. Characterization of diseased aortic valves revealed the accumulation of oxLDL in valvular tissue and reduced levels of IL-37 (an anti-inflammatory cytokine) in AVICs. Preliminary studies found that oxLDL induces AVIC expression of ALP via TLR2 and TLR4, and that IL-37 is potent in suppression of AVIC inflammosteogenic responses. Importantly, expression of IL-37 in mice attenuates obesity, hyperlipidemia and aortic valve lesions caused be high fat diet. We formulated two interrelated Aims for this project. Specific Aim 1 is to test the hypothesis that IL
37 suppresses the inflammosteogenic responses in human AVICs. We will pursue the following sub aims: A) to test the hypothesis that IL-37 deficiency in AVICs affected by CAVD augments the inflammosteogenic responses to risk factors; B) to determine the mechanism of IL-37 deficiency in AVICs of diseased human aortic valves; C) to examine the interaction of inflammatory mediators with osteogenic mediators in up-regulation of AVIC osteogenic activity; D) to test the hypothesis that recombinant IL-37 suppresses the osteogenic activity (ALP expression/activity and calcium deposit formation) in AVICs of diseased aortic valve; E) to test the hypothesis that IL-37 inhibits IRAK1 to suppress ERK1/2/NF-kB activation and the inflammosteogenic responses in human AVICs. Specific Aim 2 is to determine the effect of IL-37 on aortic valve lesions in mice fed with high fat diet. We will pursue the following sub aims: A) t test the hypothesis that TLR2/4 and IRAK1 play a critical role in mediating aortic valve lesions caused by high fat diet; B) to determine the effect of recombinant IL-37 on hyperlipidemia and aortic valve lesions caused by high fat diet; C) to determine the effect of expression of IL-37 on hyperlipidemia and aortic valve lesions caused by high fat diet. These studies will provide insights into the molecular mechanism by which risk factors induce valvular cell pro-osteogenic reprogramming. In addition, these studies will identify potential therapeutic targets for suppression of the progression of CAVD.
描述(由申请人提供):钙化性主动脉瓣疾病(CAVD)是老年人的主要心血管疾病。目前,还没有减缓或阻止这种疾病进展的药物干预。我们最近的研究发现,人主动脉瓣间质细胞(AVIC)表达炎症和成骨介质,以响应促炎刺激,并显示上调促成骨活性,其特征是碱性磷酸酶(ALP)水平升高和钙化结节的形成。病变主动脉瓣的表征揭示了oxLDL在瓣膜组织中的积累和AVIC中IL-37(一种抗炎细胞因子)水平的降低。初步研究发现,oxLDL通过TLR 2和TLR 4诱导AVIC表达ALP,并且IL-37有效抑制AVIC炎性成骨反应。重要的是,小鼠中IL-37的表达减轻了由高脂饮食引起的肥胖、高脂血症和主动脉瓣病变。我们为这个项目制定了两个相互关联的目标。具体目标1是检验IL
37抑制人AVIC中的炎性成骨反应。本研究的主要目的是:(1)验证CAVD患者AVIC中IL-37缺乏增强了对危险因素的炎性成骨反应的假说;(B)确定病变人主动脉瓣AVIC中IL-37缺乏的机制;(3)检测炎性介质与成骨介质在AVIC成骨活性上调中的相互作用; D)检验重组IL-37抑制患病主动脉瓣的AVIC中的成骨活性(ALP表达/活性和钙存款形成)的假设; E)检验IL-37抑制IRAK 1以抑制人AVIC中的ERK 1/2/NF-kB活化和炎性成骨反应的假设。具体目的2是确定IL-37对高脂饮食喂养的小鼠中的主动脉瓣病变的影响。我们将继续以下子目标:A)t检验TLR 2/4和IRAK 1在介导高脂饮食引起的主动脉瓣病变中起关键作用的假设; B)确定重组IL-37对高脂饮食引起的高脂血症和主动脉瓣病变的作用; C)确定IL-37表达对高脂饮食引起的高脂血症和主动脉瓣病变的作用。这些研究将为风险因素诱导瓣膜细胞促成骨重编程的分子机制提供见解。此外,这些研究将确定抑制CAVD进展的潜在治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIANZHONG MENG其他文献
XIANZHONG MENG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIANZHONG MENG', 18)}}的其他基金
Downregulation of Inflamm-aging for Protection Against Organ Damage in Sepsis
下调炎症衰老以防止脓毒症中的器官损伤
- 批准号:
10293589 - 财政年份:2021
- 资助金额:
$ 38.88万 - 项目类别:
Downregulation of Inflamm-aging for Protection Against Organ Damage in Sepsis
下调炎症衰老以防止脓毒症中的器官损伤
- 批准号:
10664821 - 财政年份:2021
- 资助金额:
$ 38.88万 - 项目类别:
Downregulation of Inflamm-aging for Protection Against Organ Damage in Sepsis
下调炎症衰老以防止脓毒症中的器官损伤
- 批准号:
10015500 - 财政年份:2021
- 资助金额:
$ 38.88万 - 项目类别:
Suppression of AVIC inflammosteogenesis for prevention of CAVD progression
抑制 AVIC 炎症生成以预防 CAVD 进展
- 批准号:
10220113 - 财政年份:2015
- 资助金额:
$ 38.88万 - 项目类别:
Suppression of AVIC inflammosteogenesis for prevention of CAVD progression
抑制 AVIC 炎症生成以预防 CAVD 进展
- 批准号:
10428367 - 财政年份:2015
- 资助金额:
$ 38.88万 - 项目类别:
Suppression of AVIC inflammosteogenesis for prevention of CAVD progression
抑制 AVIC 炎症生成以预防 CAVD 进展
- 批准号:
9100850 - 财政年份:2015
- 资助金额:
$ 38.88万 - 项目类别:
Suppression of AVIC inflammosteogenesis for prevention of CAVD progression
抑制 AVIC 炎症生成以预防 CAVD 进展
- 批准号:
10641833 - 财政年份:2015
- 资助金额:
$ 38.88万 - 项目类别:
Inflammatory response of aging heart to surgical myocardial ischemia
衰老心脏对手术心肌缺血的炎症反应
- 批准号:
8718962 - 财政年份:2011
- 资助金额:
$ 38.88万 - 项目类别:
Inflammatory response of aging heart to surgical myocardial ischemia
衰老心脏对手术心肌缺血的炎症反应
- 批准号:
8882208 - 财政年份:2011
- 资助金额:
$ 38.88万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 38.88万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 38.88万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 38.88万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 38.88万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 38.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 38.88万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 38.88万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 38.88万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 38.88万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 38.88万 - 项目类别:
Miscellaneous Programs